𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P063 Results of LINKER regimen in the treatment of adult acute lymphoblastic leukemia

✍ Scribed by M. Benlazar; A. Hadjeb; N. Si Ali; A. Maghraoiu; El Mestari; N. Zemri; I. Allal; Z. Zouaoui

Book ID
104323116
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
49 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

✦ Synopsis

Discussion: Our study denotes mean peroxidase value is negative in AML. Interestingly, the FAB subtypes of AML have different patterns of MPXI. All M4 and M5 cases have negative value which may be related to monocytoid cells while 75% of M3 cases have high MPXI value which may be related to high myeloperoxidase enzyme in promyelocytes. Conclusion: It is concluded that mean MPXI is negative in AML, it is almost always negative in AML M4 and M5. MPXI level may help to differentiate subtypes of AML.

πŸ“œ SIMILAR VOLUMES

Treatment of acute lymphoblastic leukemi
Treatment of acute lymphoblastic leukemia in adults
✍ Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 276 KB

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie

I17 Treatment of acute lymphoblastic leu
I17 Treatment of acute lymphoblastic leukemia in adults
✍ D. Hoelzer; N. GΒ¨okbuget πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 90 KB

Recent treatment strategies in adult ALL mainly include (1) intensification of induction and consolidation chemotherapy, (2) molecular targeting, particularly in Ph/bcr abl pos-ALL, (3) antibody therapy and (4) extension of stem cell transplantation (SCT). New diagnostic tools are used to refine def